Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: The role of nitric oxide

被引:61
作者
Chen, Hui [1 ]
Xing, Bianzhi [2 ]
Liu, Xiuheng [1 ]
Zhan, Bingyan [1 ]
Zhou, Jiangqiao [1 ]
Zhu, Hengcheng [1 ]
Chen, Zhiyuan [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Peoples R China
[2] HUST, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan, Peoples R China
关键词
ozone oxidative preconditioning; ischemia/reperfusion; NO; eNOS; iNOS; ET-1;
D O I
10.1016/j.jss.2007.12.756
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Ischemia/reperfusion (I/R) injury, which is commonly seen in the field of renal surgery or transplantation, is a major cause of acute renal failure. Previous studies have shown that ozone oxidative preconditioning (OzoneOP) attenuated renal I/R injury. The objective of this study was to examine the hypothesis that protective effects of OzoneOP in renal I/R injury were associated with endogenous NO. Materials and methods. In a right-nephrectomized rat mode, anesthetized rats underwent 45 min of renal ischemia. OzoneOP (1 mg/kg) was administered before I/R injury. Rats were killed at 24,48, and 72 h after I/R injury and blood samples and renal tissues were obtained. Results. OzoneOP prevented the renal dysfunction induced by I/R and increased nitric oxide (NO) release and renal NO synthase (endothelial, eNOS, and inducible, iNOS) expression. In contrast, enhancement of endothelin-1 in the kidney after the reperfusion was markedly suppressed by OzoneOP. Conclusions. Our findings indicated that the protective effect of OzoneOP was closely related to the NO production following the increase in eNOS and iNOS expression. Ozone treatment may have important clinical implications, particularly in view of the minimizing renal damage before transplantation. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 52 条
[1]   Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury [J].
Ajamieh, H ;
Merino, N ;
Candelario-Jalil, E ;
Menéndez, S ;
Martinez-Sanchez, G ;
Re, L ;
Giuliani, A ;
Leon, OS .
PHARMACOLOGICAL RESEARCH, 2002, 45 (04) :333-339
[2]   Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion [J].
Ajamieh, HH ;
Berlanga, J ;
Merino, N ;
Sánchez, GM ;
Carmona, AM ;
Cepero, SM ;
Giuliani, A ;
Re, L ;
León, OS .
TRANSPLANT INTERNATIONAL, 2005, 18 (05) :604-612
[3]   Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion [J].
Ajamieh, HH ;
Menéndez, S ;
Martínez-Sánchez, G ;
Candelario-Jalil, E ;
Re, L ;
Giuliani, A ;
Fernández, OSL .
LIVER INTERNATIONAL, 2004, 24 (01) :55-62
[4]   Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia [J].
Barber, E ;
Menéndez, S ;
León, OS ;
Barber, MO ;
Merino, N ;
Calunga, JL ;
Cruz, E ;
Bocci, V .
MEDIATORS OF INFLAMMATION, 1999, 8 (01) :37-41
[6]   RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
BOULANGER, C ;
LUSCHER, TF .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :587-590
[7]   GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury [J].
Chatterjee, PK ;
Patel, NSA ;
Sivarajah, A ;
Kvale, EO ;
Dugo, L ;
Cuzzocrea, S ;
Brown, PAJ ;
Stewart, KN ;
Mota-Filipe, H ;
Britti, D ;
Yaqoob, MM ;
Thiemermann, C .
KIDNEY INTERNATIONAL, 2003, 63 (03) :853-865
[8]   Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury [J].
Chatterjee, PK ;
Patel, NSA ;
Kvale, EO ;
Cuzzocrea, S ;
Brown, PAJ ;
Stewart, KN ;
Mota-Filipe, H ;
Thiemermann, C .
KIDNEY INTERNATIONAL, 2002, 61 (03) :862-871
[9]   alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats [J].
Chiao, H ;
Kohda, Y ;
McLeroy, P ;
Craig, L ;
Housini, I ;
Star, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1165-1172
[10]  
CHINTALA MS, 1993, N-S ARCH PHARMACOL, V348, P305